Moreover, we could confirm findings that CSF VILIP-1 is already increased in patients with mild cognitive impairment due to AD grouped by CDR-SOB and could therefore be a valuable marker for the early diagnosis of AD [11, 19, 20]. This evidence concerns the gene VSNL1 and Alzheimer disease.